Literature DB >> 20299674

The RAGE axis: a fundamental mechanism signaling danger to the vulnerable vasculature.

Shi Fang Yan1, Ravichandran Ramasamy, Ann Marie Schmidt.   

Abstract

The immunoglobulin superfamily molecule RAGE (receptor for advanced glycation end product) transduces the effects of multiple ligands, including AGEs (advanced glycation end products), advanced oxidation protein products, S100/calgranulins, high-mobility group box-1, amyloid-beta peptide, and beta-sheet fibrils. In diabetes, hyperglycemia likely stimulates the initial burst of production of ligands that interact with RAGE and activate signaling mechanisms. Consequently, increased generation of proinflammatory and prothrombotic molecules and reactive oxygen species trigger further cycles of oxidative stress via RAGE, thus setting the stage for augmented damage to diabetic tissues in the face of further insults. Many of the ligand families of RAGE have been identified in atherosclerotic plaques and in the infarcted heart. Together with increased expression of RAGE in diabetic settings, we propose that release and accumulation of RAGE ligands contribute to exaggerated cellular damage. Stopping the vicious cycle of AGE-RAGE and RAGE axis signaling in the vulnerable heart and great vessels may be essential in controlling and preventing the consequences of diabetes.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20299674      PMCID: PMC2862596          DOI: 10.1161/CIRCRESAHA.109.212217

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  96 in total

1.  The RAGE Gly82Ser polymorphism is not associated with cardiovascular disease in the Framingham offspring study.

Authors:  Marion A Hofmann; Qiong Yang; Evis Harja; Prashant Kedia; Peter K Gregersen; L Adrienne Cupples; Ann Marie Schmidt; Barry I Hudson
Journal:  Atherosclerosis       Date:  2005-10       Impact factor: 5.162

2.  Common polymorphisms in the glyoxalase-1 gene and their association with pro-thrombotic factors.

Authors:  Christopher P Gale; T Simon Futers; Lucinda K M Summers
Journal:  Diab Vasc Dis Res       Date:  2004-05       Impact factor: 3.291

3.  Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes.

Authors:  David M Nathan; Patricia A Cleary; Jye-Yu C Backlund; Saul M Genuth; John M Lachin; Trevor J Orchard; Philip Raskin; Bernard Zinman
Journal:  N Engl J Med       Date:  2005-12-22       Impact factor: 91.245

4.  Circulating endothelial progenitor cells are reduced in peripheral vascular complications of type 2 diabetes mellitus.

Authors:  Gian Paolo Fadini; Marta Miorin; Monica Facco; Sondra Bonamico; Ilenia Baesso; Franco Grego; Mirko Menegolo; Saula Vigili de Kreutzenberg; Antonio Tiengo; Carlo Agostini; Angelo Avogaro
Journal:  J Am Coll Cardiol       Date:  2005-05-03       Impact factor: 24.094

5.  Exogenous high-mobility group box 1 protein induces myocardial regeneration after infarction via enhanced cardiac C-kit+ cell proliferation and differentiation.

Authors:  Federica Limana; Antonia Germani; Antonella Zacheo; Jan Kajstura; Anna Di Carlo; Giovanna Borsellino; Omar Leoni; Roberta Palumbo; Luca Battistini; Raffaella Rastaldo; Susanne Müller; Giulio Pompilio; Piero Anversa; Marco E Bianchi; Maurizio C Capogrossi
Journal:  Circ Res       Date:  2005-09-15       Impact factor: 17.367

Review 6.  Advanced glycation end-product cross-link breakers. A novel approach to cardiovascular pathologies related to the aging process.

Authors:  George L Bakris; Alan J Bank; David A Kass; Joel M Neutel; Richard A Preston; Suzanne Oparil
Journal:  Am J Hypertens       Date:  2004-12       Impact factor: 2.689

7.  Release of high mobility group box 1 by dendritic cells controls T cell activation via the receptor for advanced glycation end products.

Authors:  Ingrid E Dumitriu; Paramita Baruah; Barbara Valentinis; Reinhard E Voll; Martin Herrmann; Peter P Nawroth; Bernd Arnold; Marco E Bianchi; Angelo A Manfredi; Patrizia Rovere-Querini
Journal:  J Immunol       Date:  2005-06-15       Impact factor: 5.422

8.  S100B expression modulates left ventricular remodeling after myocardial infarction in mice.

Authors:  James N Tsoporis; Alexander Marks; Abraham Haddad; Fayez Dawood; Peter P Liu; Thomas G Parker
Journal:  Circulation       Date:  2005-02-08       Impact factor: 29.690

9.  Dietary bread crust advanced glycation end products bind to the receptor for AGEs in HEK-293 kidney cells but are rapidly excreted after oral administration to healthy and subtotally nephrectomized rats.

Authors:  Veronika Somoza; Michael Lindenmeier; Thomas Hofmann; Oliver Frank; Helmut F Erbersdobler; John W Baynes; Suzanne R Thorpe; August Heidland; Holger Zill; Stephan Bek; Jochen Huber; Thomas Weigle; Sabine Scheidler; Andreas E Busch; Katarína Sebeková
Journal:  Ann N Y Acad Sci       Date:  2005-06       Impact factor: 5.691

Review 10.  Roles of the receptor for advanced glycation endproducts in diabetes-induced vascular injury.

Authors:  Hideto Yonekura; Yasuhiko Yamamoto; Shigeru Sakurai; Takuo Watanabe; Hiroshi Yamamoto
Journal:  J Pharmacol Sci       Date:  2005-03-05       Impact factor: 3.337

View more
  159 in total

Review 1.  Does aggressive glycemic control benefit macrovascular and microvascular disease in type 2 diabetes? Insights from ACCORD, ADVANCE, and VADT.

Authors:  Toni Terry; Kalyani Raravikar; Nalurporn Chokrungvaranon; Peter D Reaven
Journal:  Curr Cardiol Rep       Date:  2012-02       Impact factor: 2.931

2.  Aldose reductase (AKR1B3) regulates the accumulation of advanced glycosylation end products (AGEs) and the expression of AGE receptor (RAGE).

Authors:  Shahid P Baba; Jason Hellmann; Sanjay Srivastava; Aruni Bhatnagar
Journal:  Chem Biol Interact       Date:  2011-01-27       Impact factor: 5.192

3.  A multimodal RAGE-specific inhibitor reduces amyloid β-mediated brain disorder in a mouse model of Alzheimer disease.

Authors:  Rashid Deane; Itender Singh; Abhay P Sagare; Robert D Bell; Nathan T Ross; Barbra LaRue; Rachal Love; Sheldon Perry; Nicole Paquette; Richard J Deane; Meenakshisundaram Thiyagarajan; Troy Zarcone; Gunter Fritz; Alan E Friedman; Benjamin L Miller; Berislav V Zlokovic
Journal:  J Clin Invest       Date:  2012-03-12       Impact factor: 14.808

Review 4.  Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders.

Authors:  Berislav V Zlokovic
Journal:  Nat Rev Neurosci       Date:  2011-11-03       Impact factor: 34.870

Review 5.  Role of reactive oxygen and nitrogen species in the vascular responses to inflammation.

Authors:  Peter R Kvietys; D Neil Granger
Journal:  Free Radic Biol Med       Date:  2011-11-12       Impact factor: 7.376

6.  Effect of ageing on left ventricular compliance and distensibility in healthy sedentary humans.

Authors:  Naoki Fujimoto; Jeffrey L Hastings; Paul S Bhella; Shigeki Shibata; Nainesh K Gandhi; Graeme Carrick-Ranson; Dean Palmer; Benjamin D Levine
Journal:  J Physiol       Date:  2012-02-13       Impact factor: 5.182

7.  Hypertension induces brain β-amyloid accumulation, cognitive impairment, and memory deterioration through activation of receptor for advanced glycation end products in brain vasculature.

Authors:  Daniela Carnevale; Giada Mascio; Ivana D'Andrea; Valentina Fardella; Robert D Bell; Igor Branchi; Fabio Pallante; Berislav Zlokovic; Shirley Shidu Yan; Giuseppe Lembo
Journal:  Hypertension       Date:  2012-05-21       Impact factor: 10.190

8.  S100/Calgranulin-mediated inflammation accelerates left ventricular hypertrophy and aortic valve sclerosis in chronic kidney disease in a receptor for advanced glycation end products-dependent manner.

Authors:  Ling Yan; Liby Mathew; Bijoy Chellan; Brandon Gardner; Judy Earley; Tipu S Puri; Marion A Hofmann Bowman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-05-22       Impact factor: 8.311

9.  Identification of pheophorbide a as an inhibitor of receptor for advanced glycation end products in Mallotus japonicus.

Authors:  Teruki Matsumoto; Michiyo Matsuno; Norihito Ikui; Yoshiyuki Mizushina; Yume Omiya; Rikako Ishibashi; Taro Ueda; Hajime Mizukami
Journal:  J Nat Med       Date:  2021-02-24       Impact factor: 2.343

10.  Beneficial effects of quinoline-3-carboxamide (ABR-215757) on atherosclerotic plaque morphology in S100A12 transgenic ApoE null mice.

Authors:  Ling Yan; Per Bjork; Radu Butuc; Joseph Gawdzik; Judy Earley; Gene Kim; Marion A Hofmann Bowman
Journal:  Atherosclerosis       Date:  2013-02-28       Impact factor: 5.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.